We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Drugmakers Call Mifepristone Ruling a ‘Legal Overstep’ of FDA Authority
Drugmakers Call Mifepristone Ruling a ‘Legal Overstep’ of FDA Authority
As two dueling lawsuits over the FDA-approved medical abortion drug mifepristone appear headed to the U.S. Supreme Court, hundreds of drugmakers say Friday’s ruling in the Texas case is an overstep that could weaken the federal agency and hamper future drug development.